Showing results (1-10 of 836) with videos related to
Sort By:
Pageof 84
Current Opinion in Neurology|April 16, 2019
Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigmBruce A C Cree, Jan Mares, Hans-Peter HartungCurrent Opinion in Neurology|April 9, 2016
Steering through complexity: management approaches in multiple sclerosisBruce A C Cree, Hans-Peter HartungBiomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia|July 21, 2020
Multiple sclerosis and COVID-19Jan Mares, Hans-Peter HartungCurrent Opinion in Neurology|June 8, 2022
New drugs for multiple sclerosis: new treatment algorithmsBruce A C Cree, Hans-Peter Hartung, Michael BarnettJournal of Neurology|October 18, 2023
Multiple sclerosis: time for early treatment with high-efficacy drugsKrzysztof Selmaj, Bruce A C Cree, Michael Barnett, et al.Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 5, 2022
Monoclonal Antibodies in the Treatment of Relapsing Multiple Sclerosis: an Overview with Emphasis on Pregnancy, Vaccination, and Risk ManagementNik Krajnc, Gabriel Bsteh, Thomas Berger, et al.Current Opinion in Neurology|April 16, 2019
Diagnosis of multiple sclerosis: revisions of the McDonald criteria 2017 - continuity and changeHans-Peter Hartung, Jonas Graf, Orhan Aktas, et al.Frontiers in Immunology|January 1, 2024
Bioavailable central nervous system disease-modifying therapies for multiple sclerosisHans-Peter Hartung, Bruce A C Cree, Michael Barnett, et al.CNS Drugs|July 11, 2019
Drug Treatment of Clinically Isolated SyndromeMoritz Förster, Jonas Graf, Jan Mares, et al.Neurology(R) Neuroimmunology & Neuroinflammation|January 7, 2021
Targeting B cells to modify MS, NMOSD, and MOGAD: Part 2Jonas Graf, Jan Mares, Michael Barnett, et al.Pageof 84